½ÃÀ庸°í¼­
»óǰÄÚµå
1462665

ȯÀÚ Âü¿© ±â¼ú ½ÃÀå ¿¹Ãø(-2030³â) : Á¦°ø À¯Çü, ±¸¼º ¿ä¼Ò, Ä¡·á ¿µ¿ª, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚ ¹× Áö¿ªº° ¼¼°è ºÐ¼®

Patient Engagement Technology Market Forecasts to 2030 - Global Analysis By Delivery Type, Component, Therapeutic Area, Application, End User and by Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ µû¸£¸é, ¼¼°è ȯÀÚ Âü¿© ±â¼ú ½ÃÀåÀº 2023³â 193¾ï 8,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, ¿¹Ãø ±â°£ µ¿¾È 12.0%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 428¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ȯÀÚ Âü¿©Çü ±â¼úÀ̶ó´Â ¿ë¾î´Â »ç¶÷µéÀÌ ÀÚ½ÅÀÇ °Ç°­ °ü¸®¸¦ Ã¥ÀÓÁú ¼ö ÀÖµµ·Ï ÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÏ´Â ÀüÀÚ µµ±¸ÀÇ ÁýÇÕÀ» °¡¸®Åµ´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â °ü¸® ÀýÂ÷¸¦ °£¼ÒÈ­Çϰí, ȯÀÚ°¡ ÀÚ½ÅÀÇ °Ç°­¿¡ Àû±ØÀûÀ¸·Î Âü¿©ÇÒ ¼ö ÀÖµµ·Ï Çϸç, ȯÀÚ¿Í ÀÇ·á Àü¹®°¡ °£ÀÇ ¼ÒÅëÀ» °³¼±ÇÕ´Ï´Ù. ¶ÇÇÑ, ȯÀÚ Âü¿©Çü ±â¼úÀº Çù¾÷À» °¡´ÉÇÏ°Ô Çϰí, ÆíÀǼºÀ» Çâ»ó½Ã۸ç, ±Ã±ØÀûÀ¸·Î °Ç°­ »óŸ¦ °³¼±ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.

¹Ì±¹ ÀÇ»çÇùȸ(AMA)¿¡ µû¸£¸é, ȯÀÚ Âü¿© ±â¼úÀº ȯÀÚ°¡ Ä¡·á °áÁ¤¿¡ Àû±ØÀûÀ¸·Î Âü¿©ÇÏ°í ´õ ³ªÀº °Ç°­ °á°ú¸¦ ÃËÁøÇÔÀ¸·Î½á ÀÇ·á ¼­ºñ½º Á¦°ø¿¡ º¯È­¸¦ °¡Á®¿À´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù.

¸ÂÃãÇü ÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ´ÏÁî Áõ°¡

Çö´ë ȯÀÚµéÀº ÀÚ½ÅÀÇ ¿ä±¸»çÇ×°ú ÃëÇâ¿¡ ¸Â´Â º¸´Ù °³ÀÎÈ­µÈ ÀÇ·á ¼­ºñ½º¸¦ ¿øÇϰí ÀÖ½À´Ï´Ù. ȯÀÚ Âü¿© ±â¼úÀº ¿þ¾î·¯ºí, ¿ø°Ý ÀÇ·á Ç÷§Æû, °Ç°­ ¸ð´ÏÅ͸µ ¾Û°ú °°Àº ´Ù¾çÇÑ °³ÀÎÈ­µÈ ¼Ö·ç¼ÇÀ» Á¦°øÇÔÀ¸·Î½á ȯÀÚ°¡ ÀÚ½ÅÀÇ Ä¡·á ¿©Á¤¿¡ Àû±ØÀûÀ¸·Î Âü¿©ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº ¸Ó½Å·¯´× ¾Ë°í¸®Áò°ú µ¥ÀÌÅÍ ºÐ¼®À» ÅëÇØ °³ÀÎÈ­µÈ °Ç°­ ±ÇÀå »çÇ×, ¿¹¹æ Ä¡·á ¾Ë¸² ¹× »ýȰ½À°ü ÁßÀ縦 Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀº ȯÀÚ °³°³ÀÎÀÇ ¿ä±¸¸¦ ÃæÁ·½Ã۰í ȯÀÚ ¸¸Á·µµ¿Í Ä¡·á °èȹÀÇ ¼øÀÀµµ¸¦ ³ô¿© °Ç°­ °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¿öÅ©Ç÷οìÀÇ È¥¶õ°ú ÀÇ·á Á¦°ø¾÷üÀÇ ÀúÇ×

ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü´Â º¯È­¿¡ ´ëÇÑ ÀúÇ×, ¼­·ù ÀÛ¾÷ Áõ°¡¿¡ ´ëÇÑ ¿ì·Á, ¿öÅ©Ç÷οì È¥¶õ µîÀÇ ÀÌÀ¯·Î ȯÀÚ Âü¿©Çü ±â¼úÀ» ÀÓ»ó ¿öÅ©Ç÷ο쿡 ÅëÇÕÇÏ´Â µ¥ ¾î·Á¿òÀ» °ÞÀ» ¼ö ÀÖ½À´Ï´Ù. ¿øÈ°ÇÑ ÅëÇÕ°ú »ç¿ëÀÚ ¼ö¿ëÀ» º¸ÀåÇϱâ À§ÇØ »õ·Î¿î ±â¼úÀ» ÇöÀç Áø·á ·çƾ¿¡ ÅëÇÕÇÏ·Á¸é ½Ã°£, ±³À° ¹× Áö¿øÀÌ ÇÊ¿äÇÕ´Ï´Ù. ¶ÇÇÑ, ÀϺΠÀÇ·áÁøÀº ȯÀÚ Âü¿©Çü ±â¼úÀÌ ÀÚ½ÅÀÇ µ¶¸³¼º, Áö½Ä, ¾÷¹« ¸¸Á·µµ¸¦ À§ÇùÇÑ´Ù°í »ý°¢ÇÏ¿© ÀÌ·¯ÇÑ Çõ½Å¿¡ ȸÀÇÀûÀ̰ųª ¼ö¿ëÇÏÁö ¾ÊÀ¸·Á ÇÒ ¼öµµ ÀÖ½À´Ï´Ù.

ȯÀÚ¿Í ÀÇ·áÁø °£ÀÇ ¼ÒÅë °³¼±

ȯÀÚ Âü¿© ±â¼úÀº ȯÀÚ¿Í ÀÇ·á Àü¹®°¡ °£ÀÇ ¼ÒÅëÀ» ¿øÈ°Çϰí È¿À²ÀûÀ¸·Î °³¼±ÇÒ ¼ö ÀÖ´Â ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù. ȯÀÚ°¡ ´ëÈ­Çü ȯÀÚ Æ÷ÅÐ, ¾ÈÀüÇÑ ¸Þ½Ã¡ Ç÷§Æû, ¿ø°Ý ÀÇ·á ¼Ö·ç¼ÇÀ» ÅëÇØ Áú¹®À» Çϰí, ó¹æÀü º¸ÃæÀ» ¿äûÇϰí, ÀÇ·áÁø°ú ¼ÒÅëÇÒ ¼ö ÀÖ´Ù¸é ȯÀÚ Âü¿©¿Í ¸¸Á·µµ°¡ ³ô¾ÆÁú °ÍÀÔ´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ ±â¼úÀº Áø·á Á¶Á¤, Áø·á ¿¬¼Ó¼º, ÀÇ»ç °áÁ¤ °øÀ¯¸¦ ÃËÁøÇÏ¿© ȯÀÚ¿Í ÀÇ·áÁøÀÇ »óÈ£ÀÛ¿ëÀ» °­È­ÇÏ°í °Ç°­ °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù.

µðÁöÅÐ ¸®¼Ò½º¿Í °Ç°­¿¡ ´ëÇÑ °øÆòÇÑ Á¢±Ù¼º

ÇöÀçÀÇ °Ç°­ °ÝÂ÷¸¦ ¾ÇÈ­½ÃŰ°í µðÁöÅÐ °ÝÂ÷¸¦ È®´ëÇÏ´Â °ÍÀº ȯÀÚ Âü¿©Çü ±â¼úÀÌ °¡Á®¿Ã ¼ö ÀÖ´Â µÎ °¡Áö ÁÖ¿ä À§Çè ¿ä¼Ò Áß ÇϳªÀÔ´Ï´Ù. ȯÀÚ Âü¿©Çü µµ±¸´Â Àú¼ÒµæÃþ, °í·ÉÀÚ, ³óÃÌ °ÅÁÖÀÚ, ±â¼ú ¹× ÀÎÅͳݿ¡ ´ëÇÑ Á¢±Ù¼ºÀÌ Á¦ÇÑÀûÀÎ »ç¶÷ µî Ãë¾à °èÃþÀÌ µµÀÔ ¹× Ȱ¿ëÇϱ⠾î·Á¿ï ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼Ò¿ÜµÈ Áý´ÜÀº ÀÌ·¯ÇÑ ±â¼úÀÇ ÇýÅÿ¡¼­ ¹èÁ¦µÉ ¼ö ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ µðÁöÅÐ Çコ ¸®ÅÍ·¯½Ã ¹× ±â¼ú Á¢±Ù¼ºÀÇ ºÒÀÏÄ¡·Î ÀÎÇØ ÀÇ·á ¼º°ú¿Í ÀÇ·á Á¢±Ù¼º¿¡ ´õ Å« °ÝÂ÷°¡ ¹ß»ýÇÒ ¼ö ÀÖ½À´Ï´Ù.

COVID-19ÀÇ ¿µÇâ :

ȯÀÚ Âü¿© ±â¼úÀº Äڷγª19 ÆÒµ¥¹ÍÀ¸·Î ÀÎÇØ Å©°Ô ¼ºÀåÇϰí äÅõǰí ÀÖ½À´Ï´Ù. ÀÌ Àü¿°º´À¸·Î ÀÎÇØ Àü ¼¼°è ÀÇ·á ½Ã½ºÅÛÀº ¹ÙÀÌ·¯½º È®»êÀ» ´ÊÃß°í Ä¡·áÀÇ ¿¬¼Ó¼ºÀ» À¯ÁöÇϱâ À§ÇØ µðÁöÅÐ ¼Ö·ç¼ÇÀ¸·Î ºü¸£°Ô ÀüȯÇϰí ÀÖ½À´Ï´Ù. ÆÒµ¥¹ÍÀº °¡»ó Áø·á ÇÁ·Î±×·¥, ¿ø°Ý ÀÇ·á Ç÷§Æû, ¿ø°Ý ¸ð´ÏÅ͸µ µµ±¸ÀÇ Ã¤ÅÃÀ» °¡¼ÓÈ­Çß½À´Ï´Ù. ¶ÇÇÑ È¯ÀÚ¿Í ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü °£ÀÇ ¼ÒÅë, ¿ø°Ý Áø·á, °Ç°­ ¸ð´ÏÅ͸µÀ» ¿ëÀÌÇÏ°Ô Çϴ ȯÀÚ Âü¿©Çü ±â¼ú¿¡ ´ëÇÑ ¼ö¿äµµ ³ô¾ÆÁ³½À´Ï´Ù. ¶ÇÇÑ, ÆÒµ¥¹ÍÀº ÀÚ°¡ °ü¸®, ¿¹¹æ ¹× ¸¸¼º Áúȯ °ü¸®¿¡¼­ ȯÀÚ Âü¿©ÀÇ °¡Ä¡¸¦ ºÎ°¢½ÃÄ×½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È Ŭ¶ó¿ìµå ±â¹Ý ºÎ¹®ÀÌ °¡Àå Å« ºñÁßÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀå Á¡À¯À²ÀÌ °¡Àå Å« Ä«Å×°í¸®´Â Ŭ¶ó¿ìµå ±â¹Ý ºÎ¹®ÀÔ´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý ȯÀÚ Âü¿© ¼Ö·ç¼ÇÀÇ È®À强, À¯¿¬¼º, Á¢±Ù¼ºÀ» ÅëÇØ ÇコÄÉ¾î ±â¾÷µéÀº ´ë±Ô¸ð ÇöÀå ÀÎÇÁ¶ó ¾øÀ̵µ ¿ø°ÝÀ¸·Î ÀÌ·¯ÇÑ ±â¼úÀ» ¹èÆ÷ÇÏ°í °ü¸®ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Ŭ¶ó¿ìµå ±â¹Ý ¼Ö·ç¼ÇÀº Ŭ¶ó¿ìµå ÄÄÇ»ÆÃ ¸®¼Ò½º¿Í ¼ÒÇÁÆ®¿þ¾î ¿ëµµ¸¦ Ȱ¿ëÇÏ¿© ȯÀÚ µ¥ÀÌÅÍ¿¡ ½±°Ô Á¢±ÙÇϰí, ½Ç½Ã°£À¸·Î ¾÷µ¥ÀÌÆ®Çϸç, ´Ù¾çÇÑ ±â±â¿Í Àå¼Ò¿¡ °ÉÃÄ ÀÇ·áÁø°ú ȯÀÚ°¡ Çù¾÷ÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÕ´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµÇ´Â ºÐ¾ß´Â Á¤½Å °Ç°­ ºÐ¾ß

ȯÀÚ Âü¿© ±â¼ú ½ÃÀå¿¡¼­ °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÑ ºÐ¾ß´Â Á¤½Å °Ç°­ ºÐ¾ßÀÔ´Ï´Ù. Á¤½Å °Ç°­ °ü¸® ¹× Áö¿øÀ» À§ÇØ Æ¯º°È÷ °í¾ÈµÈ ȯÀÚ Âü¿© ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä´Â ÀÎ½Ä °³¼± ¹× ³«ÀÎ Á¦°Å ÀÌ´Ï¼ÅÆ¼ºê¿Í Á¤½Å °Ç°­ÀÌ Àü¹ÝÀûÀÎ À£ºùÀÇ Áß¿äÇÑ Ãø¸éÀ̶ó´Â ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº µðÁöÅÐ ÀÎÁöÇൿġ·á(CBT) ÇÁ·Î±×·¥, ¿ø°Ý Ä¡·á Ç÷§Æû, Á¤½Å °Ç°­ ¾Û, ±âºÐ ÃßÀû µµ±¸ µî ´Ù¾çÇÑ ¼Ö·ç¼ÇÀ» Æ÷ÇÔÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¤½Å °Ç°­ ¼­ºñ½º¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» °³¼±Çϰí, Á¶±â °³ÀÔÀ» °¡´ÉÇÏ°Ô Çϸç, »ç¶÷µéÀÌ Á¤½Å °Ç°­À» ´õ Àß °ü¸®ÇÒ ¼ö ÀÖµµ·Ï ÇÊ¿äÇÑ µµ±¸¸¦ Á¦°øÇÏ´Â °ÍÀ» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù.

°¡Àå Å« Á¡À¯À²À» °¡Áø Áö¿ª :

ºÏ¹Ì´Â Á¤±³ÇÑ ÀÇ·á ÀÎÇÁ¶ó, ³ôÀº µðÁöÅÐ Çコ ¼Ö·ç¼Ç µµÀÔ·ü, °­·ÂÇÑ ±ÔÁ¦ ȯ°æ, ÀÇ·á IT¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡·Î ÀÎÇØ ȯÀÚ Âü¿© ±â¼ú ½ÃÀå Á¡À¯À²ÀÌ °¡Àå ³ôÀº Áö¿ªÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº ȯÀÚ Áß½ÉÀÇ ÀÇ·á »ýŰ谡 ¹ß´ÞÇϰí, ȯÀÚ Áß½ÉÀû Ä¡·á¿Í °¡Ä¡ ±â¹Ý »óȯ ¸ðµ¨À» äÅÃÇϰí ÀÖ¾î ´Ù¾çÇÑ ÀÇ·á ȯ°æ¿¡¼­ ȯÀÚ Âü¿© ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ôÀº Áö¿ªÀÔ´Ï´Ù. ¶ÇÇÑ, Á¤ºÎ ±â°ü, ÀÇ·á ±â°ü ¹× ±â¼ú °ø±Þ¾÷üÀÇ Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê¸¦ ÅëÇÑ »óÈ£¿î¿ë¼º ÃËÁø, ¿ø°Ý ÀÇ·áÀÇ È®´ë ¹× ȯÀÚ Âü¿©´Â ºÏ¹Ì ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í °¡¼ÓÈ­½Ã۰í ÀÖ½À´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª :

ȯÀÚ Âü¿© ±â¼ú ½ÃÀå¿¡¼­ ¾Æ½Ã¾ÆÅÂÆò¾çÀº °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â ÀÇ·áºñ »ó½Â, ÀÇ·áºñ Áõ°¡, µðÁöÅÐ Çコ ¼Ö·ç¼ÇÀÇ Ã¤Åà Ȯ´ë, ÀÇ·á ¼­ºñ½º Á¢±Ù¼º È®´ë µîÀÇ ¿äÀο¡ ±âÀÎÇÑ °ÍÀ¸·Î ºÐ¼®µË´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¢±Ù¼º, ÀÇ·áºñ ºÎ´ã °¨¼Ò, ÀÇ·á °á°ú °³¼±À» À§ÇÑ È¯ÀÚ Âü¿© ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ´Â ÀÌ Áö¿ªÀÇ Àα¸ Áõ°¡, ÀÇ·á¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ¾çÁúÀÇ ÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±â¼ú Á¦°ø¾÷ü¿ÍÀÇ Á¦ÈÞ, ±ÔÁ¦ °³Çõ, µðÁöÅÐ Çコ Áö¿øÀ» À§ÇÑ Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê´Â ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù.

¹«·á Ä¿½ºÅ͸¶ÀÌ¡ ¼­ºñ½º

ÀÌ º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½°ú °°Àº ¹«·á ¸ÂÃãÈ­ ¿É¼Ç Áß Çϳª¸¦ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Ãß°¡ ½ÃÀå ±â¾÷ÀÇ Á¾ÇÕÀûÀÎ ÇÁ·ÎÆÄÀϸµ(ÃÖ´ë 3°³»ç±îÁö)
    • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®(ÃÖ´ë 3°³»ç)
  • Áö¿ª ¼¼ºÐÈ­
    • °í°´ÀÇ °ü½É¿¡ µû¸¥ ÁÖ¿ä ±¹°¡º° ½ÃÀå ÃßÁ¤Ä¡, ¿¹Ãø, CAGR(ÁÖ: Ÿ´ç¼º È®Àο¡ µû¶ó ´Ù¸§)
  • °æÀï»ç º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¸®Àû ÀÔÁö, Àü·«Àû Á¦ÈÞ¸¦ ±â¹ÝÀ¸·Î ÇÑ ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­¹®

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • Á¶»ç Á¢±Ù
  • Á¶»ç ¼Ò½º
    • 1Â÷ Á¶»ç ¼Ò½º
    • 2Â÷ Á¶»ç ÀÚ·á
    • ÀüÁ¦Á¶°Ç

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • À§Çù
  • ¿ëµµ ºÐ¼®
  • ÃÖÁ¾»ç¿ëÀÚ ºÐ¼®
  • ½ÅÈï ½ÃÀå
  • COVID-19ÀÇ ¿µÇâ

Á¦4Àå PorterÀÇ Five Forces ºÐ¼®

  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • ¹ÙÀ̾îÀÇ ±³¼··Â
  • ´ëüǰÀÇ À§Çù
  • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
  • °æÀï ±â¾÷°£ °æÀï °ü°è

Á¦5Àå ¼¼°èÀÇ È¯ÀÚ Âü¿© ±â¼ú ½ÃÀå : Á¦°ø À¯Çüº°

  • À¥ ±â¹Ý
  • Ŭ¶ó¿ìµå ±â¹Ý
  • ¿ÂÇÁ·¹¹Ì½º
  • ±âŸ Á¦°ø À¯Çü

Á¦6Àå ¼¼°èÀÇ È¯ÀÚ Âü¿© ±â¼ú ½ÃÀå : ÄÄÆ÷³ÍÆ®º°

  • ¼ÒÇÁÆ®¿þ¾î
  • ¼­ºñ½º
  • Çϵå¿þ¾î
  • ±âŸ ÄÄÆ÷³ÍÆ®

Á¦7Àå ¼¼°èÀÇ È¯ÀÚ Âü¿© ±â¼ú ½ÃÀå : Ä¡·á ¿µ¿ªº°

  • ¸¸¼ºÁúȯ
  • ÇÇÆ®´Ï½º
  • ¿©¼º°Ç°­
  • Á¤½Å°Ç°­
  • ±âŸ Ä¡·á ¿µ¿ª

Á¦8Àå ¼¼°èÀÇ È¯ÀÚ Âü¿© ±â¼ú ½ÃÀå : ¿ëµµº°

  • ¼Ò¼È ¸Å´ÏÁö¸ÕÆ®
  • ÀçÅà ÇコÄÉ¾î °ü¸®
  • À繫 °ÇÀü¼º °ü¸®
  • ±âŸ ¿ëµµ

Á¦9Àå ¼¼°èÀÇ È¯ÀÚ Âü¿© ±â¼ú ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ÀÇ·áºñ ÁöºÒÀÚ
  • ÀÇ·á Á¦°øÀÚ
  • ȯÀÚ
  • °³ÀÎ »ç¿ëÀÚ
  • ±âŸ ÃÖÁ¾»ç¿ëÀÚ

Á¦10Àå ¼¼°èÀÇ È¯ÀÚ Âü¿© ±â¼ú ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦11Àå ÁÖ¿ä ¹ßÀü

  • °è¾à/ÆÄÆ®³Ê½Ê/Çù¾÷/ÇÕÀÛÅõÀÚ(JV)
  • Àμö¿Í ÇÕº´
  • ½ÅÁ¦Ç° ¹ß¸Å
  • »ç¾÷ È®´ë
  • ±âŸ ÁÖ¿ä Àü·«

Á¦12Àå ±â¾÷ ÇÁ·ÎÆÄÀϸµ

  • Orion Health Ltd.
  • Medecision Inc.
  • Patientpoint, LLC
  • CipherHealth Inc
  • Oracle
  • Allscripts Healthcare, LLC
  • Phytel Inc.
  • Lincor Solutions Ltd.
  • Oneview Ltd.
  • YourCareUniverse Inc.
  • GetWellNetwork, Inc.
  • SONIFI Health Incorporated.
  • Mckesson Corporation
LSH 24.05.10

According to Stratistics MRC, the Global Patient Engagement Technology Market is accounted for $19.38 billion in 2023 and is expected to reach $42.83 billion by 2030 growing at a CAGR of 12.0% during the forecast period. The term patient engagement technology describes a group of electronic tools intended to help people take charge of their own healthcare. These tools simplify administrative procedures, enable patients to actively participate in their own health, and improve communication between patients and healthcare professionals. Moreover, patient engagement technology enables collaboration, improves convenience, and eventually results in better health outcomes.

According to the American Medical Association (AMA), patient engagement technology plays a pivotal role in transforming healthcare delivery by empowering patients to actively participate in their care decisions and promoting better health outcomes.

Market Dynamics:

Driver:

Growing need for customized medical solutions

Modern patients demand healthcare that is more individualized and tailored to their unique requirements and preferences. Patient engagement technologies enable patients to actively participate in their care journey by providing a range of personalized solutions like wearables, telehealth platforms, and health monitoring apps. These technologies use machine learning algorithms and data analytics to provide personalized health recommendations, reminders for preventive care, and lifestyle interventions. Additionally, these solutions improve health outcomes by meeting individual patient needs and improving patient satisfaction and treatment plan adherence.

Restraint:

Workflow disruptions and provider resistance

Healthcare providers may encounter difficulties incorporating patient engagement technologies into their clinical workflows because of resistance to change, concerns about increased paperwork, and workflow disruptions. In order to guarantee smooth integration and user acceptance, integrating new technologies into current practice routines takes time, training, and support. Furthermore, some medical professionals might be skeptical of or reluctant to accept these innovations because they believe that patient engagement technologies pose a threat to their independence, knowledge, or job satisfaction.

Opportunity:

Improvements in patient-provider communication

Technologies for patient engagement present chances to improve the smoothness and efficiency of communication between patients and healthcare professionals. Engagement and satisfaction are increased when patients can ask questions, request prescription refills, and communicate with their providers through interactive patient portals, secure messaging platforms, and telemedicine solutions. Additionally, these technologies facilitate care coordination, continuity of care, and shared decision-making, which enhances patient-provider interactions and improves health outcomes.

Threat:

Equitable access to digital resources and health

Exacerbating current health disparities and expanding the digital divide are two of the main risks posed by patient engagement technologies. Patient engagement tools may be difficult for vulnerable populations to adopt and use, such as low-income people, elderly patients, residents of rural areas, and people with limited access to technology or the internet. Moreover, due to the potential exclusion of marginalized groups from the benefits of these technologies, there may be even greater disparities in healthcare outcomes and access as a result of this discrepancy in digital health literacy and access to technology.

Covid-19 Impact:

Patient engagement technology has seen significant growth and adoption due to the COVID-19 pandemic, which has caused healthcare systems all over the world to quickly shift to digital solutions in an effort to slow the virus's spread and preserve continuity of care. The pandemic has accelerated the adoption of virtual care programs, telehealth platforms, and remote monitoring tools. It has also raised demand for patient engagement technologies, which facilitate communication between patients and providers as well as remote consultations and health monitoring. Additionally, the pandemic has highlighted the value of patient involvement in self-care, prevention, and the management of chronic conditions.

The Cloud Based segment is expected to be the largest during the forecast period

The category with the largest market share is the cloud-based segment. Healthcare companies can deploy and manage these technologies remotely without requiring a large amount of on-site infrastructure, thanks to the scalability, flexibility, and accessibility of cloud-based patient engagement solutions. Moreover, cloud-based solutions facilitate easy access to patient data, real-time updates, and collaboration between healthcare providers and patients across various devices and locations by utilizing cloud computing resources and software applications.

The Mental Health segment is expected to have the highest CAGR during the forecast period

The patient engagement technology market's highest CAGR is seen in the mental health segment. Demand for patient engagement technologies specifically designed for mental health management and support has increased as a result of growing awareness and destigmatization initiatives, as well as the growing recognition of mental health as a crucial aspect of overall well-being. These technologies cover a broad range of solutions, such as digital cognitive behavioural therapy (CBT) programs, teletherapy platforms, mental wellness apps, and mood tracking tools. Furthermore, their goals are to improve access to mental health services, enable early intervention, and give people the tools they need to manage their mental health more successfully.

Region with largest share:

Due to its sophisticated healthcare infrastructure, high rate of adoption of digital health solutions, strong regulatory environment, and rising investments in healthcare IT, North America is the region with the largest market share for patient engagement technology. Patient engagement technologies are in high demand across a range of healthcare settings due to the region's developed healthcare ecosystem, strong emphasis on patient-centered care, and value-based reimbursement models. Additionally, the promotion of interoperability, the expansion of telehealth, and patient engagement through strategic initiatives by government agencies, healthcare organizations, and technology vendors has further expedited the growth of the market in North America.

Region with highest CAGR:

In the patient engagement technology market, Asia-Pacific has the highest CAGR. This is due to factors like rising healthcare costs, growing healthcare expenditures, the growing adoption of digital health solutions, and expanding access to healthcare services. Investments in patient engagement technologies aimed at enhancing healthcare access, affordability, and outcomes have been stimulated by the region's growing population, growing healthcare awareness, and growing demand for high-quality healthcare. Furthermore, partnerships with technology providers, regulatory reforms, and government initiatives to support digital health have accelerated the growth of the Asia-Pacific market.

Key players in the market

Some of the key players in Patient Engagement Technology market include Orion Health Ltd., Medecision Inc., Patientpoint, LLC, CipherHealth Inc, Oracle, Allscripts Healthcare, LLC, Phytel Inc., Lincor Solutions Ltd., Oneview Ltd., YourCareUniverse Inc., GetWellNetwork, Inc., SONIFI Health Incorporated. and Mckesson Corporation.

Key Developments:

In January 2024, Finland's Orion Corp has entered into a licensing agreement with digital therapeutics (DTx) specialist Newel Health, handing over rights to an app designed to support patients with chronic pain. Newel gains exclusive worldwide rights to develop, manufacture, and commercialise the app, called Rohkea or ODD-403, which uses virtual reality to deliver a gamified treatment programme for chronic pain that specifically aims to address patients' fear of movement and re-injury.

In November 2023, Oracle signed a Memorandum of Understanding (MOU) with the Ministry of Higher Education, Scientific Research and Innovation, and the Ministry of Digital Transition and Administrative Reform. The MoU brings together the classroom to career learning resources and curriculum of Oracle Academy to all higher education institutions in Morocco, alongside Oracle University providing complementary professional digital learning journeys and certifications accessible from a dedicated Learning Portal.

In January 2023, CipherHealth has announced a partnership with Google Cloud partner SADA to enable social determinant of health (SDOH) data integration in an effort to improve patient care. SADA, together with Google Cloud, has enabled us to provide our customers with new insights into their patient populations, giving them the power to make appropriate care delivery changes that directly impact patient care, Nate Perry-Thistle, chief technology officer at CipherHealth, said in a press release.

Delivery Types Covered:

  • Web Based
  • Cloud Based
  • On Premise
  • Other Delivery Types

Components Covered:

  • Software
  • Service
  • Hardware
  • Other Components

Therapeutic Areas Covered:

  • Chronic Diseases
  • Fitness
  • Women Health
  • Mental Health
  • Other Therapeutic Areas

Applications Covered:

  • Social Management
  • Home Healthcare Management
  • Financial Health Management
  • Other Applications

End Users Covered:

  • Payers
  • Providers
  • Patients
  • Individual Users
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Patient Engagement Technology Market, By Delivery Type

  • 5.1 Introduction
  • 5.2 Web Based
  • 5.3 Cloud Based
  • 5.4 On Premise
  • 5.5 Other Delivery Types

6 Global Patient Engagement Technology Market, By Component

  • 6.1 Introduction
  • 6.2 Software
  • 6.3 Service
  • 6.4 Hardware
  • 6.5 Other Components

7 Global Patient Engagement Technology Market, By Therapeutic Area

  • 7.1 Introduction
  • 7.2 Chronic Diseases
  • 7.3 Fitness
  • 7.4 Women Health
  • 7.5 Mental Health
  • 7.6 Other Therapeutic Areas

8 Global Patient Engagement Technology Market, By Application

  • 8.1 Introduction
  • 8.2 Social Management
  • 8.3 Home Healthcare Management
  • 8.4 Financial Health Management
  • 8.5 Other Applications

9 Global Patient Engagement Technology Market, By End User

  • 9.1 Introduction
  • 9.2 Payers
  • 9.3 Providers
  • 9.4 Patients
  • 9.5 Individual Users
  • 9.6 Other End Users

10 Global Patient Engagement Technology Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Orion Health Ltd.
  • 12.2 Medecision Inc.
  • 12.3 Patientpoint, LLC
  • 12.4 CipherHealth Inc
  • 12.5 Oracle
  • 12.6 Allscripts Healthcare, LLC
  • 12.7 Phytel Inc.
  • 12.8 Lincor Solutions Ltd.
  • 12.9 Oneview Ltd.
  • 12.10 YourCareUniverse Inc.
  • 12.11 GetWellNetwork, Inc.
  • 12.12 SONIFI Health Incorporated.
  • 12.13 Mckesson Corporation
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦